Company Aclarion, Inc.

Equities

ACON

US6551872012

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change
0.2766 USD -7.74% Intraday chart for Aclarion, Inc. -5.31% -91.36%

Business Summary

Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.

Number of employees: 5

Sales per Business

USD in Million2022Weight2023Weight Delta
Delivery of Nociscan Reports
100.0 %
0 100.0 % 0 100.0 % +24.75%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
87.0 %
0 91.0 % 0 87.0 % +19.27%
Non-United States
13.0 %
0 9.0 % 0 13.0 % +80.19%

Managers

Managers TitleAgeSince
Chief Executive Officer 57 21-09-14
Director of Finance/CFO 61 21-09-30
Corporate Officer/Principal 52 21-09-14

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 15-12-31
Chairman 59 20-08-31
Director/Board Member 52 22-04-20
Chief Executive Officer 57 21-09-14
Director/Board Member 52 16-08-31
Director/Board Member 46 22-04-20
Director/Board Member 68 22-04-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 7,153,500 7,015,344 ( 98.07 %) 0 98.07 %

Shareholders

NameEquities%Valuation
70,406 0.9842 % 23 164 $
CapFinancial Partners LLC
0.4145 %
29,652 0.4145 % 9 756 $
27,492 0.3843 % 9 045 $
25,339 0.3542 % 8 337 $
22,352 0.3125 % 7 354 $
David Neal
0.1630 %
11,658 0.1630 % 3 835 $
3,296 0.0461 % 1 084 $
Geode Capital Management LLC
0.0274 %
1,957 0.0274 % 644 $
Citadel Securities GP LLC
0.0242 %
1,729 0.0242 % 569 $
HRT Financial LLC
0.0229 %
1,638 0.0229 % 539 $
NameEquities%Valuation
Armistice Capital LLC
-
550,000 - 19 250 $
Worth Venture Partners LLC
-
286,276 - 10 020 $
Hudson Bay Capital Management LP
-
160,000 - 5 600 $
CapFinancial Partners LLC
-
78,400 - 2 744 $
Clear Street LLC
-
47,162 - 1 651 $
Warberg Asset Management LLC
-
15,000 - 525 $

Company contact information

Aclarion, Inc.

8181 Arista Place Suite 100

80021, Broomfield

+833 275 2266

http://www.nocimed.com
address Aclarion, Inc.(ACON)
  1. Stock Market
  2. Equities
  3. ACON Stock
  4. Company Aclarion, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW